Skip to main content

Table 3 Distribution of rs662799 polymorphism in the APOA5 gene in ESKD patients with and without CVD

From: Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients

 

Genotypes

MAF

OR (95% CI)a

N

TT

TC

CC

 

C allele

CC genotypeb

TC genotypeb

ESKD CVD + 

552

423 (76.7)

105 (19)

24 (4.3)

0.14

2.41 (1.61–3.6)

3.13 (1.07–9.14)

2.38 (1.47–3.85)

      

p < 0.001

p = 0.036

p < 0.001

ESKD CVD-

248

221 (89.1)

23 (9.3)

4 (1.6)

0.06

ref

ref

ref

  1. Genotype distribution is shown as numbers (%)
  2. ESKD End-stage kidney disease, CVD Cardiovascular disease, APOA5 Apolipoprotein A5, MAF Minor allele frequency
  3. aAdjusted for age, sex, BMI, hypertension and diabetes
  4. bCalculated versus TT genotype
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us